Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for BEHANDLUNG VON HEPATISCHER ENZEPHALOPATHIE UNTER VERWENDUNG VON RIFAXIMIN
Details for 2019207534
Up to date per 10.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2019207534
Title / Product Name
BEHANDLUNG VON HEPATISCHER ENZEPHALOPATHIE UNTER VERWENDUNG VON RIFAXIMIN
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2019207534
EP Publication Number
3628319
E-Number
1656468
Language
EN
PCT Number
Publication Date
01.04.2020 A
14.02.2024 B1
Registration Date
14.02.2024
AT Publication Date
15.03.2024
Application Date
02.10.2009
Registration Number
-
Priorities
02.10.2008
US
102349 P
IPC
A61K 31/437 20060101AFI20200130BHEP
Maximum Duration of Protection
02.10.2029
Owner
Salix Pharmaceuticals, Inc.
8450 Colonnade Center Drive, Colonnade 1
Raleigh, NC, 27615
US
Representative
No representatives present
Inventor
FORBES, William
1008 Heydon Court
Raleigh, NC 27164
US
Information about Fees
Click here to load the fees